DK464686D0 - PREPARED CONTROLLED DELIVERY OF THE ACTIVE SUBSTANCE - Google Patents

PREPARED CONTROLLED DELIVERY OF THE ACTIVE SUBSTANCE

Info

Publication number
DK464686D0
DK464686D0 DK464686A DK464686A DK464686D0 DK 464686 D0 DK464686 D0 DK 464686D0 DK 464686 A DK464686 A DK 464686A DK 464686 A DK464686 A DK 464686A DK 464686 D0 DK464686 D0 DK 464686D0
Authority
DK
Denmark
Prior art keywords
active substance
controlled delivery
prepared controlled
prepared
delivery
Prior art date
Application number
DK464686A
Other languages
Danish (da)
Other versions
DK170016B1 (en
DK464686A (en
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK464686D0 publication Critical patent/DK464686D0/en
Publication of DK464686A publication Critical patent/DK464686A/en
Application granted granted Critical
Publication of DK170016B1 publication Critical patent/DK170016B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK464686A 1985-10-01 1986-09-29 Composition with controlled release of the active substance DK170016B1 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB8524135 1985-10-01
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB8524653 1985-10-07
GB8531419 1985-12-20
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB8603097 1986-02-07
GB8605037 1986-02-28
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (3)

Publication Number Publication Date
DK464686D0 true DK464686D0 (en) 1986-09-29
DK464686A DK464686A (en) 1987-04-02
DK170016B1 DK170016B1 (en) 1995-05-01

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464686A DK170016B1 (en) 1985-10-01 1986-09-29 Composition with controlled release of the active substance

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (en) * 2001-02-20 2008-10-15 Dinan Timothy Gerard TREATING FIBROMYALGIA WITH PINDOLOL
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
KR870003777A (en) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (en) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (en) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (en) 2003-04-03
IE862565L (en) 1987-04-01
DK170016B1 (en) 1995-05-01
HK392A (en) 1992-01-10
ES2002508A6 (en) 1988-08-16
FR2589732B1 (en) 1989-07-13
NZ217732A (en) 1990-07-26
DE3632201A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04
FR2589732A1 (en) 1987-05-15
CA1298784C (en) 1992-04-14
SE8604112L (en) 1987-04-02
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
ATA260486A (en) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (en) 1987-04-02
AT402257B (en) 1997-03-25
CH669524A5 (en) 1989-03-31
PT83456B (en) 1989-05-12
DE3632201C2 (en) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (en) 2002-12-02
SE8604112D0 (en) 1986-09-29
DK464686A (en) 1987-04-02
BE905516A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
DK324385A (en) PHARMACEUTICAL PREPARATION WITH CONTROLLED RELEASE OF THE ACTIVE SUBSTANCE
DK165730C (en) COMPOSITION FOR THE DELIVERY OF HYDROPHOBIC MEDICINES AND ITS PREPARATION
DK243286D0 (en) MANUFACTURING SYSTEM FOR THE DELIVERY OF ACTIVE INGREDIENTS
DK158770C (en) APPLICATION OF PAROXETIN FOR THE PREPARATION OF ANTI-MEDICINE MEDICINE
DK354385A (en) LIPOSOM COMPATIBLE SURFACTIVE SUBSTANCE
NO862956D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDINE DERIVATIVES.
NO864879L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIAZOLO COMPOUNDS.
NO862373D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES.
DK106685D0 (en) CONTROLLED DELIVERY OF ACTIVE SUBSTANCE AND PROCEDURE FOR PREPARING THEREOF
NO171592C (en) PROCEDURE FOR THE PREPARATION OF ACTIVE CINNOLIN DERIVATIVES
DK165984C (en) PROCEDURE FOR THE PREPARATION OF SPHINGOSIN DERIVATIVES
DK396286A (en) INJECTABLE FORMULATION WITH DELAYED DELIVERY OF THE ACTIVE INGREDIENT
DK524489D0 (en) PROCEDURE FOR THE PREPARATION OF BIOLOGICALLY ACTIVE COMPOUNDS, SPECIAL ENZYMER
DK516286D0 (en) PROCEDURE FOR THE PREPARATION OF OXAZOLD DERIVATIVES
DK268783A (en) INSECTICIDE COMPOSITIONS WITH HIGH CONCENTRATION OF ACTIVE SUBSTANCE
DK586586D0 (en) BIOLOGICALLY ACTIVE AMID DERIVATIVES
DK522986D0 (en) PROCEDURE FOR ADMINISTRATION OF ETHANOLAMINE DERIVATIVES FOR PETS
DK464686A (en) PREPARED CONTROLLED DELIVERY OF THE ACTIVE SUBSTANCE
DK115291A (en) PROCEDURE FOR THE PREPARATION OF AMPOTER SURFACTIVE IMIDAZOLINE DERIVATIVES
DK163980A (en) PROCEDURE FOR THE PREPARATION OF A BIOLOGICALLY ACTIVE SUBSTANCE 41.200RP WITH IMMUNICULATIVE EFFECT
DK162631C (en) COMPOUND, designated FR-900216, FOR USE AS THERAPEUTIC ACTIVE SUBSTANCE, PHARMACEUTICAL PREPARATION CONTAINING THE COMPOUND AND USING THE COMPOUND
DK206985A (en) TRANSDERMAL DOSAGE FORM WITH IMPROVED IMPROVEMENT OF THE ACTIVE SUBSTANCE
DK258886D0 (en) PROCEDURE FOR THE PREPARATION OF ALKYLOXIRANES
DK509986A (en) PROCEDURE FOR THE PREPARATION OF ARYL-CYANAMIDES
LV5394A3 (en) Sediment for obtaining a medicament with controlled release of the active substance

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired